Review





Similar Products

99
ATCC monocyte leukemia cell line thp1
Monocyte Leukemia Cell Line Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monocyte leukemia cell line thp1/product/ATCC
Average 99 stars, based on 1 article reviews
monocyte leukemia cell line thp1 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

96
InvivoGen monocytic nf κb seap reporter cell line called thp
Monocytic Nf κb Seap Reporter Cell Line Called Thp, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monocytic nf κb seap reporter cell line called thp/product/InvivoGen
Average 96 stars, based on 1 article reviews
monocytic nf κb seap reporter cell line called thp - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

99
ATCC thp1 monocytes
Effect of the test compounds on the growth of the activated macrophages from <t>THP1</t> monocytes (the results were the average of the five independent experiments).
Thp1 Monocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thp1 monocytes/product/ATCC
Average 99 stars, based on 1 article reviews
thp1 monocytes - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
ATCC thp1 human monocyte cells
Effect of the test compounds on the growth of the activated macrophages from <t>THP1</t> monocytes (the results were the average of the five independent experiments).
Thp1 Human Monocyte Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thp1 human monocyte cells/product/ATCC
Average 99 stars, based on 1 article reviews
thp1 human monocyte cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
ATCC human monocyte thp1
Effect of the test compounds on the growth of the activated macrophages from <t>THP1</t> monocytes (the results were the average of the five independent experiments).
Human Monocyte Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human monocyte thp1/product/ATCC
Average 99 stars, based on 1 article reviews
human monocyte thp1 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
ATCC human monocyte leukemia cells thp1
( A ) The coculture system. Human or mouse tumor cells were pretreated with IFN-β for 48 hours and cocultured with <t>THP1-derived</t> macrophages (THP1-MΦ) or RAW264.7 cells for another 48 hours. The macrophages were collected for analysis. ( B ) Heatmap showing the ISG15 , IFI44 , CXCL9 , CXCL10 , and SPP1 mRNA expression in cocultured THP1-MΦ. ( C ) Relative Cxcl9 and Cxcl10 expression in cocultured RAW264.7 cells. ( D ) CD86 and HLA-DR expression on cocultured THP1-MΦ. ( E ) CD40 expression on RAW264.7 cells cocultured with Usp5-deficient CT26 cells. ( F ) p-STAT2 and p-STAT1 in large extracellular vesicles (LEVs) from the culture medium of USP5-deficient SUNE1 and HK1 cells after IFN-β treatment. ( G ) p-STAT1 and p-STAT2 levels in THP1-MΦ after coculture with SUNE1 cells. ( H – J ) THP1-MΦ were treated with LEVs collected from the culture medium of STAT2-EGFP–transfected control and USP5-deficient SUNE1 cells after IFN-β treatment. The proportion of EGFP + macrophages ( H ), CD86 and HLA-DR expression ( I ), and relative CXCL9 and CXCL1 expression ( J ) in EGFP + and EGFP – macrophages were measured. ( K – M ) Indicated B16 tumors were subjected to irradiation on day 10 after inoculation. The proportions of CXCL9 + CD11b + macrophages measured by multiplex immunofluorescent staining ( K , n = 6 per group), the iNOS + CD11b + macrophages and IFN-γ + TNF-α + CD8 + T cells measured by flow cytometry ( L , n = 5 per group), and tumor growth ( M , n = 6 per group) are reported. The results are representative of 3 independent experiments ( B – J ). Data are presented as mean ± SD. Comparisons were performed using 1-way ANOVA ( H ) or 2-way ANOVA with Bonferroni’s test ( C – E and I – M ) for multiple comparisons. ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Human Monocyte Leukemia Cells Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human monocyte leukemia cells thp1/product/ATCC
Average 99 stars, based on 1 article reviews
human monocyte leukemia cells thp1 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
ATCC human leukemia monocytic thp1 cells
( A ) The coculture system. Human or mouse tumor cells were pretreated with IFN-β for 48 hours and cocultured with <t>THP1-derived</t> macrophages (THP1-MΦ) or RAW264.7 cells for another 48 hours. The macrophages were collected for analysis. ( B ) Heatmap showing the ISG15 , IFI44 , CXCL9 , CXCL10 , and SPP1 mRNA expression in cocultured THP1-MΦ. ( C ) Relative Cxcl9 and Cxcl10 expression in cocultured RAW264.7 cells. ( D ) CD86 and HLA-DR expression on cocultured THP1-MΦ. ( E ) CD40 expression on RAW264.7 cells cocultured with Usp5-deficient CT26 cells. ( F ) p-STAT2 and p-STAT1 in large extracellular vesicles (LEVs) from the culture medium of USP5-deficient SUNE1 and HK1 cells after IFN-β treatment. ( G ) p-STAT1 and p-STAT2 levels in THP1-MΦ after coculture with SUNE1 cells. ( H – J ) THP1-MΦ were treated with LEVs collected from the culture medium of STAT2-EGFP–transfected control and USP5-deficient SUNE1 cells after IFN-β treatment. The proportion of EGFP + macrophages ( H ), CD86 and HLA-DR expression ( I ), and relative CXCL9 and CXCL1 expression ( J ) in EGFP + and EGFP – macrophages were measured. ( K – M ) Indicated B16 tumors were subjected to irradiation on day 10 after inoculation. The proportions of CXCL9 + CD11b + macrophages measured by multiplex immunofluorescent staining ( K , n = 6 per group), the iNOS + CD11b + macrophages and IFN-γ + TNF-α + CD8 + T cells measured by flow cytometry ( L , n = 5 per group), and tumor growth ( M , n = 6 per group) are reported. The results are representative of 3 independent experiments ( B – J ). Data are presented as mean ± SD. Comparisons were performed using 1-way ANOVA ( H ) or 2-way ANOVA with Bonferroni’s test ( C – E and I – M ) for multiple comparisons. ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Human Leukemia Monocytic Thp1 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human leukemia monocytic thp1 cells/product/ATCC
Average 99 stars, based on 1 article reviews
human leukemia monocytic thp1 cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
ATCC p ril 2023 human monocyte line thp1 cells
( A ) The coculture system. Human or mouse tumor cells were pretreated with IFN-β for 48 hours and cocultured with <t>THP1-derived</t> macrophages (THP1-MΦ) or RAW264.7 cells for another 48 hours. The macrophages were collected for analysis. ( B ) Heatmap showing the ISG15 , IFI44 , CXCL9 , CXCL10 , and SPP1 mRNA expression in cocultured THP1-MΦ. ( C ) Relative Cxcl9 and Cxcl10 expression in cocultured RAW264.7 cells. ( D ) CD86 and HLA-DR expression on cocultured THP1-MΦ. ( E ) CD40 expression on RAW264.7 cells cocultured with Usp5-deficient CT26 cells. ( F ) p-STAT2 and p-STAT1 in large extracellular vesicles (LEVs) from the culture medium of USP5-deficient SUNE1 and HK1 cells after IFN-β treatment. ( G ) p-STAT1 and p-STAT2 levels in THP1-MΦ after coculture with SUNE1 cells. ( H – J ) THP1-MΦ were treated with LEVs collected from the culture medium of STAT2-EGFP–transfected control and USP5-deficient SUNE1 cells after IFN-β treatment. The proportion of EGFP + macrophages ( H ), CD86 and HLA-DR expression ( I ), and relative CXCL9 and CXCL1 expression ( J ) in EGFP + and EGFP – macrophages were measured. ( K – M ) Indicated B16 tumors were subjected to irradiation on day 10 after inoculation. The proportions of CXCL9 + CD11b + macrophages measured by multiplex immunofluorescent staining ( K , n = 6 per group), the iNOS + CD11b + macrophages and IFN-γ + TNF-α + CD8 + T cells measured by flow cytometry ( L , n = 5 per group), and tumor growth ( M , n = 6 per group) are reported. The results are representative of 3 independent experiments ( B – J ). Data are presented as mean ± SD. Comparisons were performed using 1-way ANOVA ( H ) or 2-way ANOVA with Bonferroni’s test ( C – E and I – M ) for multiple comparisons. ** P < 0.01, *** P < 0.001, **** P < 0.0001.
P Ril 2023 Human Monocyte Line Thp1 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p ril 2023 human monocyte line thp1 cells/product/ATCC
Average 99 stars, based on 1 article reviews
p ril 2023 human monocyte line thp1 cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

Image Search Results


Effect of the test compounds on the growth of the activated macrophages from THP1 monocytes (the results were the average of the five independent experiments).

Journal: RSC Advances

Article Title: Development of substituted 2-(4-(sulfonyl)piperazin-1-yl)quinazoline molecular hybrids as a new class of antimalarials

doi: 10.1039/d5ra08515b

Figure Lengend Snippet: Effect of the test compounds on the growth of the activated macrophages from THP1 monocytes (the results were the average of the five independent experiments).

Article Snippet: Lung cancer A549 epithelial cells and THP1 monocytes were obtained from ATCC.

Techniques:

( A ) The coculture system. Human or mouse tumor cells were pretreated with IFN-β for 48 hours and cocultured with THP1-derived macrophages (THP1-MΦ) or RAW264.7 cells for another 48 hours. The macrophages were collected for analysis. ( B ) Heatmap showing the ISG15 , IFI44 , CXCL9 , CXCL10 , and SPP1 mRNA expression in cocultured THP1-MΦ. ( C ) Relative Cxcl9 and Cxcl10 expression in cocultured RAW264.7 cells. ( D ) CD86 and HLA-DR expression on cocultured THP1-MΦ. ( E ) CD40 expression on RAW264.7 cells cocultured with Usp5-deficient CT26 cells. ( F ) p-STAT2 and p-STAT1 in large extracellular vesicles (LEVs) from the culture medium of USP5-deficient SUNE1 and HK1 cells after IFN-β treatment. ( G ) p-STAT1 and p-STAT2 levels in THP1-MΦ after coculture with SUNE1 cells. ( H – J ) THP1-MΦ were treated with LEVs collected from the culture medium of STAT2-EGFP–transfected control and USP5-deficient SUNE1 cells after IFN-β treatment. The proportion of EGFP + macrophages ( H ), CD86 and HLA-DR expression ( I ), and relative CXCL9 and CXCL1 expression ( J ) in EGFP + and EGFP – macrophages were measured. ( K – M ) Indicated B16 tumors were subjected to irradiation on day 10 after inoculation. The proportions of CXCL9 + CD11b + macrophages measured by multiplex immunofluorescent staining ( K , n = 6 per group), the iNOS + CD11b + macrophages and IFN-γ + TNF-α + CD8 + T cells measured by flow cytometry ( L , n = 5 per group), and tumor growth ( M , n = 6 per group) are reported. The results are representative of 3 independent experiments ( B – J ). Data are presented as mean ± SD. Comparisons were performed using 1-way ANOVA ( H ) or 2-way ANOVA with Bonferroni’s test ( C – E and I – M ) for multiple comparisons. ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: The Journal of Clinical Investigation

Article Title: LC3-dependent intercellular transfer of phosphorylated STAT1/2 elicits CXCL9 + macrophages and enhances radiation-induced antitumor immunity

doi: 10.1172/JCI195279

Figure Lengend Snippet: ( A ) The coculture system. Human or mouse tumor cells were pretreated with IFN-β for 48 hours and cocultured with THP1-derived macrophages (THP1-MΦ) or RAW264.7 cells for another 48 hours. The macrophages were collected for analysis. ( B ) Heatmap showing the ISG15 , IFI44 , CXCL9 , CXCL10 , and SPP1 mRNA expression in cocultured THP1-MΦ. ( C ) Relative Cxcl9 and Cxcl10 expression in cocultured RAW264.7 cells. ( D ) CD86 and HLA-DR expression on cocultured THP1-MΦ. ( E ) CD40 expression on RAW264.7 cells cocultured with Usp5-deficient CT26 cells. ( F ) p-STAT2 and p-STAT1 in large extracellular vesicles (LEVs) from the culture medium of USP5-deficient SUNE1 and HK1 cells after IFN-β treatment. ( G ) p-STAT1 and p-STAT2 levels in THP1-MΦ after coculture with SUNE1 cells. ( H – J ) THP1-MΦ were treated with LEVs collected from the culture medium of STAT2-EGFP–transfected control and USP5-deficient SUNE1 cells after IFN-β treatment. The proportion of EGFP + macrophages ( H ), CD86 and HLA-DR expression ( I ), and relative CXCL9 and CXCL1 expression ( J ) in EGFP + and EGFP – macrophages were measured. ( K – M ) Indicated B16 tumors were subjected to irradiation on day 10 after inoculation. The proportions of CXCL9 + CD11b + macrophages measured by multiplex immunofluorescent staining ( K , n = 6 per group), the iNOS + CD11b + macrophages and IFN-γ + TNF-α + CD8 + T cells measured by flow cytometry ( L , n = 5 per group), and tumor growth ( M , n = 6 per group) are reported. The results are representative of 3 independent experiments ( B – J ). Data are presented as mean ± SD. Comparisons were performed using 1-way ANOVA ( H ) or 2-way ANOVA with Bonferroni’s test ( C – E and I – M ) for multiple comparisons. ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: The human monocyte leukemia cells THP1, mouse monocyte-macrophage leukemia cells RAW264.7, B16 murine melanoma cells, and MC38 and CT26 murine colon adenocarcinoma cells were obtained from American Type Culture Collection (ATCC).

Techniques: Derivative Assay, Expressing, Transfection, Control, Irradiation, Multiplex Assay, Staining, Flow Cytometry

( A ) The cytosolic and nuclear p-STAT1 and p-STAT2 levels in WT and USP5-deficient SUNE1 cells. ( B ) Representative confocal microscopy images and line scan analysis showing the different localization of p-STAT2 in WT or USP5-deficient SUNE1 cells. Scale bar: 10 μm. ( C ) Bubble diagram shows the enriched biological process of anti-STAT2 immunoprecipitated proteins in USP5-deficient SUNE1 cells after IFN-β treatment. ( D ) Volcano plot shows 1,353 upregulated and 566 downregulated proteins (FC ≥ 1.5 and P < 0.05) in anti-STAT2 immunoprecipitates from USP5-deficient compared with control SUNE1 cells. ( E and F ) Co-IP shows the interaction between STAT2 and LC3B-II in USP5-deficient SUNE1 cells ( E ) and HK1 cells ( F ) after IFN-β treatment. ( G and H ) Representative immunofluorescence assay images ( G ) showing the colocalization of p-STAT2 and LC3B in USP5-deficient SUNE1 cells after IFN-β treatment. Scale bar: 10 μm. ( H ) The Manders’ colocalization coefficients are reported. ( I ) The decreased p-STAT2 and p-STAT1 in large extracellular vesicles (LEVs) from the culture medium of USP5-deficient SUNE1 after LC3B knockdown. ( J ) LC3B knockdown in STAT2-EGFP SUNE1 cells decreased the EGFP + population in coculture with THP1-MΦ. ( K and L ) Control and USP5-deficient SUNE1 cells were transfected with si-LC3B and treated with IFN-β for 48 hours. LEVs were collected from the culture medium and used to treat the THP1-MΦ. The relative CXCL 9 and CXCL10 expression in macrophages was measured by RT-qPCR ( K ); the CD86 and HLA-DR expression on macrophages was measured by flow cytometry ( L ). The results are representative of 3 independent experiments ( A , B , and E – L ). The data are presented as mean ± SD ( H and J – L ). Comparisons were performed using 1-way ANOVA ( H ) or 2-way ANOVA ( J – L ) with Bonferroni’s test for multiple comparisons. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: The Journal of Clinical Investigation

Article Title: LC3-dependent intercellular transfer of phosphorylated STAT1/2 elicits CXCL9 + macrophages and enhances radiation-induced antitumor immunity

doi: 10.1172/JCI195279

Figure Lengend Snippet: ( A ) The cytosolic and nuclear p-STAT1 and p-STAT2 levels in WT and USP5-deficient SUNE1 cells. ( B ) Representative confocal microscopy images and line scan analysis showing the different localization of p-STAT2 in WT or USP5-deficient SUNE1 cells. Scale bar: 10 μm. ( C ) Bubble diagram shows the enriched biological process of anti-STAT2 immunoprecipitated proteins in USP5-deficient SUNE1 cells after IFN-β treatment. ( D ) Volcano plot shows 1,353 upregulated and 566 downregulated proteins (FC ≥ 1.5 and P < 0.05) in anti-STAT2 immunoprecipitates from USP5-deficient compared with control SUNE1 cells. ( E and F ) Co-IP shows the interaction between STAT2 and LC3B-II in USP5-deficient SUNE1 cells ( E ) and HK1 cells ( F ) after IFN-β treatment. ( G and H ) Representative immunofluorescence assay images ( G ) showing the colocalization of p-STAT2 and LC3B in USP5-deficient SUNE1 cells after IFN-β treatment. Scale bar: 10 μm. ( H ) The Manders’ colocalization coefficients are reported. ( I ) The decreased p-STAT2 and p-STAT1 in large extracellular vesicles (LEVs) from the culture medium of USP5-deficient SUNE1 after LC3B knockdown. ( J ) LC3B knockdown in STAT2-EGFP SUNE1 cells decreased the EGFP + population in coculture with THP1-MΦ. ( K and L ) Control and USP5-deficient SUNE1 cells were transfected with si-LC3B and treated with IFN-β for 48 hours. LEVs were collected from the culture medium and used to treat the THP1-MΦ. The relative CXCL 9 and CXCL10 expression in macrophages was measured by RT-qPCR ( K ); the CD86 and HLA-DR expression on macrophages was measured by flow cytometry ( L ). The results are representative of 3 independent experiments ( A , B , and E – L ). The data are presented as mean ± SD ( H and J – L ). Comparisons were performed using 1-way ANOVA ( H ) or 2-way ANOVA ( J – L ) with Bonferroni’s test for multiple comparisons. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: The human monocyte leukemia cells THP1, mouse monocyte-macrophage leukemia cells RAW264.7, B16 murine melanoma cells, and MC38 and CT26 murine colon adenocarcinoma cells were obtained from American Type Culture Collection (ATCC).

Techniques: Confocal Microscopy, Immunoprecipitation, Control, Co-Immunoprecipitation Assay, Immunofluorescence, Knockdown, Transfection, Expressing, Quantitative RT-PCR, Flow Cytometry

( A ) Ubiquitination of STAT2 in control and USP5-depleted cells after IFN-β treatment. ( B ) The binding of STAT2 and LC3B-II in USP5-deficient SUNE1 cells after WT or C335A-mutated USP5 restoration and IFN-β treatment. ( C ) PRY41 treatment decreased p-STAT1 and p-STAT2 levels in LEVs from USP5-deficient SUNE1 cells. ( D ) Knockout of USP5 increased K63O-linked ubiquitination of STAT2 in IFN-β–treated SUNE1 cells. ( E ) Mass spectrometry analysis of STAT2 ubiquitination sites. ( F ) Ubiquitination of FLAG-tagged WT and K167R, K197R, and K239R-STAT2 mutants in USP5-deficient SUNE1 cells. ( G ) Representative confocal microscopy images showing the different localization of phosphorylated WT or K167R-mutated STAT2 in WT or USP5-deficient SUNE1 cells. Scale bar: 10 μm. ( H and I ) The colocalization relationship and Manders’ colocalization coefficients between p-STAT2 and LC3B in STAT2- and USP5-deficient SUNE1 cells with WT STAT2 or K167R-mutant reconstruction and IFN-β treatment. Scale bar: 10 μm. ( J ) The binding between LC3B with WT or K167R-STAT2 in SUNE1 cells after IFN-β treatment. ( K ) The p-STAT1 and p-STAT2 levels in LEVs collected from the culture medium of STAT2-deficient SUNE1 cells transfected with WT or K167R-mutated STAT2 after IFN-β treatment. ( L and M ) Control and USP5-deficient SUNE1 cells were transfected with WT STAT2 or K167R-mutant and treated with IFN-β for 48 hours. LEVs were collected from culture medium and treated for THP1-MΦ. The CXCL 9 and SPP1 expression in macrophages was measured by RT-qPCR ( L ), and the CD86 expression on macrophages was measured by flow cytometry ( M ). The results are representative of 3 independent experiments ( A – D and F – M ). The data are presented as mean ± SD. Comparisons were performed using 2-way ANOVA with Bonferroni’s test ( I , L , and M ) for multiple comparisons. ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: The Journal of Clinical Investigation

Article Title: LC3-dependent intercellular transfer of phosphorylated STAT1/2 elicits CXCL9 + macrophages and enhances radiation-induced antitumor immunity

doi: 10.1172/JCI195279

Figure Lengend Snippet: ( A ) Ubiquitination of STAT2 in control and USP5-depleted cells after IFN-β treatment. ( B ) The binding of STAT2 and LC3B-II in USP5-deficient SUNE1 cells after WT or C335A-mutated USP5 restoration and IFN-β treatment. ( C ) PRY41 treatment decreased p-STAT1 and p-STAT2 levels in LEVs from USP5-deficient SUNE1 cells. ( D ) Knockout of USP5 increased K63O-linked ubiquitination of STAT2 in IFN-β–treated SUNE1 cells. ( E ) Mass spectrometry analysis of STAT2 ubiquitination sites. ( F ) Ubiquitination of FLAG-tagged WT and K167R, K197R, and K239R-STAT2 mutants in USP5-deficient SUNE1 cells. ( G ) Representative confocal microscopy images showing the different localization of phosphorylated WT or K167R-mutated STAT2 in WT or USP5-deficient SUNE1 cells. Scale bar: 10 μm. ( H and I ) The colocalization relationship and Manders’ colocalization coefficients between p-STAT2 and LC3B in STAT2- and USP5-deficient SUNE1 cells with WT STAT2 or K167R-mutant reconstruction and IFN-β treatment. Scale bar: 10 μm. ( J ) The binding between LC3B with WT or K167R-STAT2 in SUNE1 cells after IFN-β treatment. ( K ) The p-STAT1 and p-STAT2 levels in LEVs collected from the culture medium of STAT2-deficient SUNE1 cells transfected with WT or K167R-mutated STAT2 after IFN-β treatment. ( L and M ) Control and USP5-deficient SUNE1 cells were transfected with WT STAT2 or K167R-mutant and treated with IFN-β for 48 hours. LEVs were collected from culture medium and treated for THP1-MΦ. The CXCL 9 and SPP1 expression in macrophages was measured by RT-qPCR ( L ), and the CD86 expression on macrophages was measured by flow cytometry ( M ). The results are representative of 3 independent experiments ( A – D and F – M ). The data are presented as mean ± SD. Comparisons were performed using 2-way ANOVA with Bonferroni’s test ( I , L , and M ) for multiple comparisons. ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: The human monocyte leukemia cells THP1, mouse monocyte-macrophage leukemia cells RAW264.7, B16 murine melanoma cells, and MC38 and CT26 murine colon adenocarcinoma cells were obtained from American Type Culture Collection (ATCC).

Techniques: Ubiquitin Proteomics, Control, Binding Assay, Knock-Out, Mass Spectrometry, Confocal Microscopy, Mutagenesis, Transfection, Expressing, Quantitative RT-PCR, Flow Cytometry

( A ) USP5-IN-1 increased STAT2 ubiquitination in SUNE1 and HK1 cells after IFN-β treatment. ( B ) Co-IP shows that the USP5-IN-1 treatment promotes the interaction between STAT2 and LC3B-II. ( C ) Immunofluorescence assay and representative images show the colocalization of p-STAT2 and LC3B in USP5-IN-1– and IFN-β–treated SUNE1 and HK1 cells. Scale bar: 10 μm. The Manders’ colocalization coefficients are reported. ( D ) Western blot showing the p-STAT1 and p-STAT2 levels in large extracellular vesicles (LEVs) from SUNE1 and HK1 cells treated with USP5-IN-1 and IFN-β. ( E and F ) Relative mRNA expression of ISG15 , IFI44 , CXCL9 , CXCL10 , and SPP1 ( E ), and HLA-DR and CD86 expression ( F ) in THP1-MΦ after coculture with SUNE1 cells pretreated with DMSO or USP5-IN-1 and IFN-β. The results are representative of 3 independent experiments ( A – F ). The data are presented as mean ± SD. Comparisons were performed using 2-way ANOVA with Bonferroni’s test ( C and F ) for multiple comparisons. * P < 0.05, **** P < 0.0001.

Journal: The Journal of Clinical Investigation

Article Title: LC3-dependent intercellular transfer of phosphorylated STAT1/2 elicits CXCL9 + macrophages and enhances radiation-induced antitumor immunity

doi: 10.1172/JCI195279

Figure Lengend Snippet: ( A ) USP5-IN-1 increased STAT2 ubiquitination in SUNE1 and HK1 cells after IFN-β treatment. ( B ) Co-IP shows that the USP5-IN-1 treatment promotes the interaction between STAT2 and LC3B-II. ( C ) Immunofluorescence assay and representative images show the colocalization of p-STAT2 and LC3B in USP5-IN-1– and IFN-β–treated SUNE1 and HK1 cells. Scale bar: 10 μm. The Manders’ colocalization coefficients are reported. ( D ) Western blot showing the p-STAT1 and p-STAT2 levels in large extracellular vesicles (LEVs) from SUNE1 and HK1 cells treated with USP5-IN-1 and IFN-β. ( E and F ) Relative mRNA expression of ISG15 , IFI44 , CXCL9 , CXCL10 , and SPP1 ( E ), and HLA-DR and CD86 expression ( F ) in THP1-MΦ after coculture with SUNE1 cells pretreated with DMSO or USP5-IN-1 and IFN-β. The results are representative of 3 independent experiments ( A – F ). The data are presented as mean ± SD. Comparisons were performed using 2-way ANOVA with Bonferroni’s test ( C and F ) for multiple comparisons. * P < 0.05, **** P < 0.0001.

Article Snippet: The human monocyte leukemia cells THP1, mouse monocyte-macrophage leukemia cells RAW264.7, B16 murine melanoma cells, and MC38 and CT26 murine colon adenocarcinoma cells were obtained from American Type Culture Collection (ATCC).

Techniques: Ubiquitin Proteomics, Co-Immunoprecipitation Assay, Immunofluorescence, Western Blot, Expressing